Trade Mark Journal No.2025/025 20 June 2025

UK00004214969 6 June 2025 (10,44)

PRECISE MRD

International priority date claimed: 15 January 2025 (United States of America) (98965020)

Class 10: Medical test kit related to detection of circulating DNA derived from cancerous cells, comprising specimen collection containers, printed instructions, and materials for transmitting specimens, all in the medical field.
Class 44: Medical testing services related to detection of circulating DNA derived from cancerous cells; genetic and genomic testing related to detection of circulating DNA derived from cancerous cells.

Myriad Genetics, Inc.

Representative: HGF Limited